Dow performance: Pfizer moves ahead of GE into the #7 slot
Pfizer is now up by 15.0% for 2012 with GE up by 14.1%. With just one trading session left in the year and with Eliquis being approved by the FDA after hours, PFE is very likely to wind up the year in seventh place. It was #3 last year and is the only stock other than HD to be in the Top Ten in both 2011 and 12012.
The full rankings for 2012 will be posted here on Jan. 1.